JP2021533126A5 - - Google Patents

Info

Publication number
JP2021533126A5
JP2021533126A5 JP2021505674A JP2021505674A JP2021533126A5 JP 2021533126 A5 JP2021533126 A5 JP 2021533126A5 JP 2021505674 A JP2021505674 A JP 2021505674A JP 2021505674 A JP2021505674 A JP 2021505674A JP 2021533126 A5 JP2021533126 A5 JP 2021533126A5
Authority
JP
Japan
Prior art keywords
pharmaceutical product
product according
raav
mammal
viral vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021505674A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021533126A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/044290 external-priority patent/WO2020028466A1/en
Publication of JP2021533126A publication Critical patent/JP2021533126A/ja
Publication of JP2021533126A5 publication Critical patent/JP2021533126A5/ja
Priority to JP2024001612A priority Critical patent/JP7890339B2/ja
Pending legal-status Critical Current

Links

JP2021505674A 2018-07-31 2019-07-31 臓器機能を制御するための遺伝子治療方法 Pending JP2021533126A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024001612A JP7890339B2 (ja) 2018-07-31 2024-01-10 臓器機能を制御するための遺伝子治療方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862712669P 2018-07-31 2018-07-31
US62/712,669 2018-07-31
PCT/US2019/044290 WO2020028466A1 (en) 2018-07-31 2019-07-31 Gene therapy methods to control organ function

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024001612A Division JP7890339B2 (ja) 2018-07-31 2024-01-10 臓器機能を制御するための遺伝子治療方法

Publications (2)

Publication Number Publication Date
JP2021533126A JP2021533126A (ja) 2021-12-02
JP2021533126A5 true JP2021533126A5 (cg-RX-API-DMAC7.html) 2022-08-01

Family

ID=69230802

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021505674A Pending JP2021533126A (ja) 2018-07-31 2019-07-31 臓器機能を制御するための遺伝子治療方法
JP2024001612A Active JP7890339B2 (ja) 2018-07-31 2024-01-10 臓器機能を制御するための遺伝子治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024001612A Active JP7890339B2 (ja) 2018-07-31 2024-01-10 臓器機能を制御するための遺伝子治療方法

Country Status (14)

Country Link
US (1) US20210301306A1 (cg-RX-API-DMAC7.html)
EP (1) EP3829718A4 (cg-RX-API-DMAC7.html)
JP (2) JP2021533126A (cg-RX-API-DMAC7.html)
KR (1) KR20210052450A (cg-RX-API-DMAC7.html)
CN (1) CN113301956B (cg-RX-API-DMAC7.html)
AU (1) AU2019315445A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021001878A2 (cg-RX-API-DMAC7.html)
CA (1) CA3108324A1 (cg-RX-API-DMAC7.html)
EA (1) EA202190358A1 (cg-RX-API-DMAC7.html)
IL (1) IL280531A (cg-RX-API-DMAC7.html)
MX (1) MX2021001336A (cg-RX-API-DMAC7.html)
PH (1) PH12021550243A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202101042SA (cg-RX-API-DMAC7.html)
WO (1) WO2020028466A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013230776B2 (en) 2012-03-08 2015-12-03 Medtronic Af Luxembourg S.A.R.L. Immune system neuromodulation and associated systems and methods
AU2015358385B2 (en) 2014-12-03 2020-09-03 Medtronic Ireland Manufacturing Unlimited Company Systems and methods for modulating nerves or other tissue
US10524859B2 (en) 2016-06-07 2020-01-07 Metavention, Inc. Therapeutic tissue modulation devices and methods
CN115707773A (zh) * 2021-08-20 2023-02-21 中国科学院深圳先进技术研究院 一种利用交感神经控制血管内皮细胞异质性的方法
WO2023019565A1 (zh) * 2021-08-20 2023-02-23 中国科学院深圳先进技术研究院 一种利用交感神经控制血管内皮细胞异质性的方法
CN116019909B (zh) * 2022-09-16 2025-07-29 上海市第十人民医院 一种CRISPR/Cas9纳米系统
CN116115758B (zh) * 2022-11-22 2024-12-03 上海市内分泌代谢病研究所 Gabaa受体作为靶点在制备或筛选降血脂、治疗肥胖和/或改善代谢的药物中的应用
CN120699131B (zh) * 2024-12-04 2025-12-09 良渚实验室 治疗帕金森病的化学遗传学基因治疗新方案

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US4863457A (en) 1986-11-24 1989-09-05 Lee David A Drug delivery device
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5814618A (en) 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
US5464758A (en) 1993-06-14 1995-11-07 Gossen; Manfred Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US6342390B1 (en) 1994-11-23 2002-01-29 The United States Of America As Represented By The Secretary Of Health And Human Services Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy
FR2814642B1 (fr) 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
CA2566257A1 (en) 2004-05-07 2005-11-24 Applera Corporation Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof
DE23193606T1 (de) * 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
DK2561073T3 (en) 2010-04-23 2016-12-12 Univ Massachusetts Aav vectors targeted to central nervous system and methods of use thereof
EP4124346A3 (en) * 2012-06-19 2023-04-19 University of Florida Research Foundation, Inc. Compositions and methods for treating diseases
GB201403684D0 (en) * 2014-03-03 2014-04-16 King S College London Vector
WO2016054557A1 (en) * 2014-10-03 2016-04-07 University Of Massachusetts Novel high efficiency library-identified aav vectors
AU2016324317A1 (en) * 2015-09-17 2018-03-08 Coda Biotherapeutics, Inc. Compositions and methods for treating neurological disorders
US20170218842A1 (en) * 2016-02-02 2017-08-03 General Electric Company Adjusting Airflow Distortion in Gas Turbine Engine
CA3011939A1 (en) * 2016-02-02 2017-08-10 University Of Massachusetts Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
EP3426307B1 (en) * 2016-03-09 2023-09-06 Assaf, Fadi Using dreadd for neuronal modulation in treating neuronal diseases
MA44546B1 (fr) * 2016-06-15 2021-03-31 Univ California Virus adéno-associés variants et procédés d'utilisation
JPWO2018008770A1 (ja) * 2016-07-06 2019-04-18 厚範 神谷 末梢神経を操作する方法、脳および脊髄を除く臓器などにおいて神経細胞機能を変化させる機能を発生させる方法、および新規疾病の予防または治療方法、ならびに末梢神経投与用医薬
IL292382A (en) * 2019-10-22 2022-06-01 Applied Genetic Tech Corporation Adeno-associated virus (aav) systems for treatment of progranulin associated neurodegenerative diseases or disorders

Similar Documents

Publication Publication Date Title
Tan et al. Projections of preBötzinger complex neurons in adult rats
JP2015508760A5 (cg-RX-API-DMAC7.html)
US20140234275A1 (en) Method for treating als via the increased production of factor h
JP2021533126A (ja) 臓器機能を制御するための遺伝子治療方法
JP2024019727A5 (cg-RX-API-DMAC7.html)
JP7229284B2 (ja) グルカゴン類似ペプチド-1受容体亢進剤を含む筋減少症治療用薬学組成物
WO2004111250A1 (ja) アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター
WO2021121166A1 (zh) 用于癌症治疗的多靶向siRNA
JP2019514902A (ja) 経口投与用遺伝子伝達のためのナノ粒子およびこれを含む薬学組成物
JP2011511090A5 (cg-RX-API-DMAC7.html)
Papa et al. Nanovector-mediated drug delivery in spinal cord injury: a multitarget approach
CN108883186B (zh) 序贯抗癌治疗
JP2015510889A (ja) 中枢神経系障害を治療するための核酸ナノ粒子を中枢神経系へ送達する方法
US20220347321A1 (en) Expression of neuropeptides
Yuan et al. Calcitonin gene‐related peptide antagonists in the treatment of episodic migraine
CN112353940B (zh) 一种用于预防或治疗抑郁症的药物及其应用
McCain The future of gene therapy
CN116672435A (zh) LRP1-β链短肽在治疗胰岛素抵抗和糖尿病中的应用
CN116656704A (zh) 用于治疗法布里病的转基因表达盒
RS51481B (sr) Lečenje amiotrofične lateralne skleroze
Liu et al. Non-viral gene delivery and therapeutics targeting to brain
Bhagwat et al. Neurogenesis: gene-based strategies for treating ischemic stroke
Simonato et al. Gene Therapy for Neurological Diseases
TWI857661B (zh) 利用奈米膠囊藥物傳送系統且用於產生食慾素神經肽的組合物及其用於製備藥物的用途
Alavijeh et al. Advances in Genetic Medicine. Highlights from The Society for Medicines Research Online Meeting. Virtual-December 3, 2020